Insulet
PODD
#2015
Rank
C$13.91 B
Marketcap
C$200.58
Share price
-3.69%
Change (1 day)
-56.99%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): C$0.85 Billion

According to Insulet's latest financial reports the company's current earnings are C$3.18 Billion. In 2025 the company made an earning of C$0.57 Billion, an increase over its 2024 earnings that were of C$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.85 B49.24%
2025 C$0.57 B16.3%
2024 C$0.49 B36.76%
2023 C$0.35 B481.9%
2022 C$61.76 M-45.24%
2021 C$0.11 B43.35%
2020 C$78.66 M18.51%
2019 C$66.38 M41.16%
2018 C$47.02 M-711.95%
2017 -C$7.69 Million-56.85%
2016 -C$17.82 Million-79.31%
2015 -C$86.11 Million63.85%
2014 -C$52.55 Million31.04%
2013 -C$40.11 Million-21.96%
2012 -C$51.39 Million
2010 -C$49.01 Million-42.38%
2009 -C$85.06 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$77.16 Million209.75%
2006 -C$24.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.82 B 2,977.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.34 B 1,086.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$10.50 B 1,104.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$49.82 B 5,614.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$87.41 Million-110.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.11 B-86.38%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.82 B 109.70%๐Ÿ‡บ๐Ÿ‡ธ USA